This study aims to evaluate the cost-benefit of vaccination services, mostly partial series administration, provided by a mobile clinic program (MCP) in Houston for children of transient and low-income families. The study included 469 patients who visited the mobile clinics on regular service days in 2 study periods in 2014 and 836 patients who attended vaccination events in the summer of 2014. The benefit of partial series vaccination was estimated based on vaccine efficacy/effectiveness data. Our conservative cost-benefit estimates show that, compared with office-based settings, every dollar spent on vaccination by the MCP would result in $0.9 societal cost averted as an incremental benefit in regular service days and $3.7 during vaccination-only events. To further improve the cost-benefit of vaccination services in the MCP, decision-makers and stakeholders may consider improving work efficiency during regular service days or hosting more vaccination events.
ZickafooseJSDavisMM.Medical home disparities are not created equal: differences in the medical home for children from different vulnerable groups. J Health Care Poor Underserved. 2013;24:1331-1343.
2.
OriolNECotePJVavsisAP, et al. Calculating the return on investment of mobile healthcare. BMC Med. 2009;7:27: doi:10.1186/1741-7015-7-27
3.
MorphewTScottLLiM, et al. Mobile health care operations and return on investment in predominantly underserved children with asthma: the Breathmobile program. Popul Health Manag. 2013;16:261-269.
4.
SongZHillCBennetJVavasisAOriolNE.Mobile clinic in Massachusetts associated with cost savings from lowering blood pressure and emergency department use. Health Aff (Millwood). 2013;32:36-44.
5.
EdgerlyLPEl-SayedYYDruzinMLKiernanMDanielsKI.Use of a community mobile health van to increase early access to prenatal care. Matern Child Health J. 2007;11:235-239.
6.
ArevaloOSamanDMBonaimeASkeltonJ.Mobile dental units: leasing or buying? A dollar-cost analysis. J Public Health Dent. 2010;70:253-257.
ZhouFSheferAWengerJ, et al. Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics. 2014;133:577-585.
DemicheliVTibertiD.The effectiveness and safety of hepatitis A vaccine: a systematic review. Vaccine. 2003;21:2242-2245.
11.
GoldsteinSTZhouFHadlerSCBellBPMastEEMargolisHS.A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005;34:1329-1339.
12.
KreimerARStruyfFDel Rosario-RaymundoMR, et al. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica vaccine and PATRICIA trials. Lancet. 2015;16:775-786.
13.
Centers for Disease Control and Prevention. Paralytic poliomyelitis—Senegal, 1986-1987: update on the N-IPV efficacy study. MMWR Morb Mortal Wkly Rep. 1988;37(16):257-259.
VesikariTMatsonDODennehyP, et al; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
16.
BoomJATateJESahniLC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010;125:e199-e207.
17.
StaatMAPayneDCDonauerS, et al; New Vaccine Surveillance Network (NVSN). Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics. 2011;128:e267-e275.
18.
CorteseMMLeblancJWhiteKE, et al. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics. 2011;128:e1474-e1481.
19.
Ruiz-PalaciosGMPérez-SchaelIVelázquezFR, et al; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
20.
ChessonHWEkwuemeDUSaraiyaMDunneEFMarkowitzLE.The cost-effectiveness of male HPV vaccination in the United States. Vaccine. 2011;29:8443-8450.
21.
ProsserLABridgesCBUyekiTM, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006;12:1548-1558.
Centers for Disease Control and Prevention. Estimated vaccination coverage with individual vaccines and selected vaccination series among children aged 19-35 months living below the poverty level by state and selected area—National Immunization Survey (NIS), United States, 2014. https://www.cdc.gov/vaccines/imz-managers/coverage/…/tab14_pov_iap_2014.xlsx. Accessed March 20, 2017.
Centers for Disease Control and Prevention. Influenza vaccination coverage estimates for persons 6 months and older by State, HHS Region, and the United States, National Immunization Survey-Flu (NIS-Flu) and Behavioral Risk Factor Surveillance System (BRFSS), 2010-11 through 2015-16 influenza seasons. https://ndmsia.cdc.gov/IAS/data/excel?viewId=1357&geoId=3&subsetId=&viewer=Excel. Accessed April 2, 2017.
27.
SrivastavAZhaiYSantibanezTAKahnKESmithPJSingletonJA.Influenza vaccination coverage of Vaccine for Children (VFC)-entitled versus privately insured children, United States, 2011-2013. Vaccine. 2015;33:3114-3121.
ShimEBrownSTDePasseJ, et al. Cost effectiveness of influenza vaccine for US children: live attenuated and inactivated influenza vaccine. Am J Prev Med. 2016;51:309-317.
30.
CaspardHGaglaniMClipperL, et al. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States. Vaccine. 2016;34:77-82.
31.
EncisoRSundaresanSYekikianMMulliganR.Oral health status of children attending a mobile dental clinic—a comparative study. J Health Care Poor Underserved. 2015;26:1418-1427. doi:10.1353/hpu.2015.0121
32.
GibsonBAMoranoJPWaltonMR, et al. Innovative program delivery and determinants of frequent visitation to a mobile medical clinic in an urban setting. J Health Care Poor Underserved. 2017;28:643-662. doi:10.1353/hpu.2017.0065
33.
YuSWYHillCRicksMLBennetJOriolNE. The scope and impact of mobile health clinics in the United States: a literature review. Int J Equity Health. 2017;16:178. doi:10.1186/s12939-017-0671-2
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
